UroGen Pharma Ltd. - Ordinary Shares (URGN) by event type
URGN moves most on coverage initiations — a median of -1.00% at 30 minutes across 16 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the URGN overview →
How URGN reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 2,107 of 2,283 | 16 | -1.00% | 19% | -3.26% |
| Rating reiterations 273 of 3,522 | 117 | +0.33% | 54% | +0.41% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how URGN usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · URGN overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PolarityTE, Inc. (PTE) | 670 | -0.62% | 38% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 664 | -0.07% | 48% |
| Brainstorm Cell Therapeutics Inc. (BCLI) | 660 | 0.00% | 47% |
| OPHTHOTECH CORP COMMON (OPHT) | 660 | -0.20% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.